Annual Cash & Cash Equivalents
$1.18 M
-$16.94 M-93.47%
December 31, 2023
Summary
- As of February 7, 2025, TLSA annual cash & cash equivalents is $1.18 million, with the most recent change of -$16.94 million (-93.47%) on December 31, 2023.
- During the last 3 years, TLSA annual cash & cash equivalents has fallen by -$64.64 million (-98.20%).
- TLSA annual cash & cash equivalents is now -98.20% below its all-time high of $65.82 million, reached on December 31, 2020.
Performance
TLSA Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.13 M
-$53.00 K-4.48%
June 1, 2024
Summary
- As of February 7, 2025, TLSA quarterly cash and cash equivalents is $1.13 million, with the most recent change of -$53.00 thousand (-4.48%) on June 1, 2024.
- Over the past year, TLSA quarterly cash and cash equivalents has dropped by -$53.00 thousand (-4.48%).
- TLSA quarterly cash and cash equivalents is now -98.28% below its all-time high of $65.82 million, reached on December 31, 2020.
Performance
TLSA Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
TLSA Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -93.5% | -4.5% |
| 3 y3 years | -98.2% | -93.8% |
| 5 y5 years | -77.6% | -93.8% |
TLSA Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.2% | at low | -97.3% | at low |
| 5 y | 5-year | -98.2% | +489.7% | -98.3% | +463.3% |
| alltime | all time | -98.2% | -100.0% | -98.3% | -100.0% |
Tiziana Life Sciences Ltd Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $1.13 M(-4.5%) |
| Dec 2023 | $1.18 M(-93.5%) | $1.18 M(-82.1%) |
| Jun 2023 | - | $6.60 M(-63.6%) |
| Dec 2022 | $18.12 M(-57.0%) | $18.12 M(-31.7%) |
| Jun 2022 | - | $26.54 M(-37.1%) |
| Dec 2021 | $42.19 M(-35.9%) | $42.19 M(-21.0%) |
| Jun 2021 | - | $53.43 M(-18.8%) |
| Dec 2020 | $65.82 M(>+9900.0%) | $65.82 M(+642.7%) |
| Jun 2020 | - | $8.86 M(+4317.9%) |
| Dec 2019 | $200.60 K(-96.2%) | - |
| Dec 2019 | - | $200.60 K(-64.4%) |
| Jun 2019 | - | $563.90 K(-89.3%) |
| Dec 2018 | $5.29 M(+8043.3%) | $5.29 M(+6024.0%) |
| Jun 2018 | - | $86.30 K(+33.0%) |
| Dec 2017 | $64.90 K(-98.9%) | - |
| Dec 2017 | - | $64.90 K(-97.5%) |
| Jun 2017 | - | $2.61 M(-55.0%) |
| Dec 2016 | $5.80 M(-56.0%) | - |
| Dec 2016 | - | $5.80 M(-47.5%) |
| Jun 2016 | - | $11.05 M(-16.2%) |
| Dec 2015 | $13.19 M(+274.0%) | - |
| Dec 2015 | - | $13.19 M(+20.5%) |
| Jun 2015 | - | $10.94 M(+210.3%) |
| Dec 2014 | $3.53 M(>+9900.0%) | - |
| Dec 2014 | - | $3.53 M(-41.7%) |
| Jun 2014 | - | $6.05 M(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | - |
| Dec 2013 | - | $0.00(-100.0%) |
| Jun 2013 | - | $3000.00(-53.8%) |
| Dec 2012 | $6500.00(-87.3%) | - |
| Dec 2012 | - | $6500.00(-91.0%) |
| Jun 2012 | - | $72.30 K |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $51.20 K(+5.6%) | - |
| Dec 2011 | - | $51.20 K(-93.1%) |
| Jun 2011 | - | $745.80 K(+299.5%) |
| Jun 2010 | - | $186.70 K(+284.9%) |
| Dec 2009 | $48.50 K(+32.5%) | - |
| Dec 2009 | - | $48.50 K(-28.0%) |
| Jun 2009 | - | $67.40 K(+84.2%) |
| Dec 2008 | $36.60 K(-96.9%) | - |
| Dec 2008 | - | $36.60 K(-89.6%) |
| Jun 2008 | - | $352.30 K(-69.8%) |
| Dec 2007 | $1.17 M(+17.2%) | - |
| Dec 2007 | - | $1.17 M(-54.6%) |
| Jun 2007 | - | $2.57 M(+158.3%) |
| Dec 2006 | $995.30 K(-38.5%) | - |
| Dec 2006 | - | $995.30 K(-12.7%) |
| Jun 2006 | - | $1.14 M(-29.6%) |
| Dec 2005 | $1.62 M(+9.5%) | - |
| Dec 2005 | - | $1.62 M(+58.0%) |
| Jun 2005 | - | $1.02 M(-30.7%) |
| Dec 2004 | $1.48 M(-16.9%) | - |
| Dec 2004 | - | $1.48 M(-29.0%) |
| Jun 2004 | - | $2.08 M(+17.2%) |
| Dec 2003 | $1.78 M(>+9900.0%) | - |
| Dec 2003 | - | $1.78 M(+2398.0%) |
| Jun 2003 | - | $71.20 K(+530.1%) |
| Dec 2002 | $11.30 K(-99.3%) | - |
| Dec 2002 | - | $11.30 K(-99.0%) |
| Jun 2002 | - | $1.08 M |
| Dec 2001 | $1.60 M(-50.9%) | - |
| Dec 2000 | $3.25 M(+1180.7%) | - |
| Dec 1999 | $254.00 K(-72.8%) | - |
| Dec 1998 | $934.50 K | - |
FAQ
- What is Tiziana Life Sciences Ltd annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Tiziana Life Sciences Ltd?
- What is Tiziana Life Sciences Ltd annual cash & cash equivalents year-on-year change?
- What is Tiziana Life Sciences Ltd quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Tiziana Life Sciences Ltd?
- What is Tiziana Life Sciences Ltd quarterly cash and cash equivalents year-on-year change?
What is Tiziana Life Sciences Ltd annual cash & cash equivalents?
The current annual cash & cash equivalents of TLSA is $1.18 M
What is the all time high annual cash & cash equivalents for Tiziana Life Sciences Ltd?
Tiziana Life Sciences Ltd all-time high annual cash & cash equivalents is $65.82 M
What is Tiziana Life Sciences Ltd annual cash & cash equivalents year-on-year change?
Over the past year, TLSA annual cash & cash equivalents has changed by -$16.94 M (-93.47%)
What is Tiziana Life Sciences Ltd quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of TLSA is $1.13 M
What is the all time high quarterly cash and cash equivalents for Tiziana Life Sciences Ltd?
Tiziana Life Sciences Ltd all-time high quarterly cash and cash equivalents is $65.82 M
What is Tiziana Life Sciences Ltd quarterly cash and cash equivalents year-on-year change?
Over the past year, TLSA quarterly cash and cash equivalents has changed by -$53.00 K (-4.48%)